electroCore, Inc. (ECOR) Gross Margin
- Gross margin · 12 months: Value 87.06%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 87.06% | Gross profit / revenue. Period ending 2026-06-30. $32.18M ÷ $36.97M × 100 ≈ 87.06% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 32.18M USD | Gross Profit |
| Revenue | 36.97M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 4.79M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $32.18M | $36.97M | $4.79M | 87.06% |
| 2026-03-31 | $30.45M | $34.90M | $4.45M | 87.25% |
| 2025-12-31 | $27.79M | $32.03M | $4.24M | 86.75% |
| 2025-09-30 | $25.67M | $29.84M | $4.17M | 86.04% |
| 2025-06-30 | $23.69M | $27.70M | $4.01M | 85.52% |
| 2025-03-31 | $22.55M | $26.46M | $3.91M | 85.22% |
| 2024-12-31 | $21.40M | $25.18M | $3.79M | 84.97% |
| 2024-09-30 | $19.44M | (m) | $3.89M | (m) |
| 2024-06-30 | $17.79M | $21.28M | $3.49M | 83.61% |
| 2024-03-31 | $15.46M | $18.69M | $3.23M | 82.70% |
| 2023-12-31 | $13.23M | (m) | $2.80M | (m) |
| 2023-09-30 | $11.05M | $13.40M | $2.34M | 82.51% |
| 2023-06-30 | $8.93M | $10.87M | $1.94M | 82.14% |
| 2023-03-31 | $7.76M | $9.47M | $1.71M | 81.91% |
| 2022-12-31 | $6.98M | $8.59M | $1.62M | 81.19% |
| 2022-09-30 | $6.26M | $7.52M | $1.27M | 83.15% |
| 2022-06-30 | $5.67M | $7.03M | $1.37M | 80.59% |
| 2022-03-31 | $4.77M | $6.15M | $1.38M | 77.53% |
| 2021-12-31 | $4.07M | $5.45M | $1.39M | 74.59% |
| 2021-09-30 | $2.98M | $4.89M | $1.91M | 60.88% |
| 2021-06-30 | $2.58M | $4.48M | $1.90M | 57.51% |
| 2021-03-31 | $2.16M | $3.97M | $1.80M | 54.53% |
| 2020-12-31 | $1.76M | $3.50M | $1.74M | 50.30% |
| 2020-09-30 | $1.93M | $3.24M | $1.31M | 59.62% |
| 2020-06-30 | $1.53M | $2.84M | $1.32M | 53.74% |
| 2020-03-31 | $1.42M | $2.71M | $1.30M | 52.21% |
| 2019-12-31 | $1.23M | $2.39M | $1.16M | 51.60% |
| 2019-09-30 | $1.12M | $2.08M | $958.41K | 53.99% |
| 2019-06-30 | $849.34K | $1.55M | $701.54K | 54.77% |
| 2019-03-31 | $633.78K | $1.32M | $687.59K | 47.96% |
| 2018-12-31 | $414.21K | $992.95K | $578.74K | 41.71% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $775.46K | (m) | (m) |
| 2017-12-31 | $292.93K | $811.46K | $518.53K | 36.10% |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |